Page last updated: 2024-10-21

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and Psoriasis

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid has been researched along with Psoriasis in 1 studies

15-hydroxy-5,8,11,13,17-eicosapentaenoic acid: structure given in first source; RN given refers to parent cpd

Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miller, C1
Yamaguchi, RY1
Ziboh, VA1

Other Studies

1 other study available for 15-hydroxy-5,8,11,13,17-eicosapentaenoic acid and Psoriasis

ArticleYear
Guinea pig epidermis generates putative anti-inflammatory metabolites from fish oil polyunsaturated fatty acids.
    Lipids, 1989, Volume: 24, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chromatography, High Pressure Liquid; Docosahexaen

1989